Clinical Trial Update: Mechanisms of Immunosurveillance for Lung Cancer

View source ↗

Summary

A completed clinical trial update examining immunosurveillance mechanisms in lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Lung Cancer | Status: COMPLETED